Heparin-Coated Palmaz-Schatz Stents in Human Coronary Arteries
Patrick W. Serruys(Erasmus MC), Marie‐Angèle Morel(Unknown), Carlos Macaya(Hospital Clínico San Carlos), Guy R. Heyndrickx(Onze Lieve Vrouwziekenhuis Hospital), Ferdinand Kiemeney(Erasmus University Rotterdam), Antonio Colombo(Humanitas University), Wolfgang Rutsch(Freie Universität Berlin), Hans Bonnier(Erasmus University Rotterdam), Victor Legrand(Centre Hospitalier Universitaire de Liège), Anthony C. Lunn(Erasmus University Rotterdam), Jean Fajadet(Clinique Pasteur), Marie‐Claude Morice(Institut Cardiovasculaire Paris Sud), Peter de Jaegere(Rotterdam University of Applied Sciences), Harry Suryapranata(Erasmus University Rotterdam), J J Goy(University Hospital of Lausanne), Eulogio Garcı́a(Erasmus University Rotterdam), Wim van der Giessen(Rotterdam University of Applied Sciences), Håkan Emanuelsson(AstraZeneca (Sweden)), Jorge Belardi(Instituto Cardiovascular de Buenos Aires), Pierre Materne(Centre hospitalier régional de la Citadelle), Peter Ruygrok(Erasmus University Rotterdam)
Cited by 404
Related Papers
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2009|7.1k
Clinical End Points in Coronary Stent Trials
|Circulation|2007|5.4k
A Comparison of Balloon-Expandable-Stent Implantation with Balloon Angioplasty in Patients with Coronary Artery Disease
|New England Journal of Medicine|1994|4.5k
A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization
|New England Journal of Medicine|2002|4k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.7k